<ul><li><div>`{{c1::<b>Pott's Disease</b>}}` is a possible complication of <b>extrapulmonary Tuberculosis</b> that involves spread of infection to <u>`{{c2::vertebral bodies}}`</u></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-48052094108001.jpg" draggable="false"><img src="/Users/michaelroth/AnkingImages/paste-48064979010087.jpg" draggable="false"></div></li></ul></li><li><div><b>Primary TB</b> classically forms a(n)&nbsp;<b>`{{c1::Ghon complex}}`</b>, which is a <u>calcified</u> <b>granulomatous lesion</b> with <b>hilar lymphadenopathy</b></div><ul><li><div><i>when a Ghon complex heals and calcifies further, it may be referred to as a <b>Ranke</b> <b>complex</b></i><img src="/Users/michaelroth/AnkingImages/paste-244070106530336.jpg" /></div></li></ul></li><li><div><b><u>Both</u></b><i> Mycobacteria tuberculosis and leprae</i> stain `{{c1::<u>acid-fast</u>}}`, taking up the <b>`{{c2::carbol fuchsin}}`</b> stain</div><ul><li><div>aka Ziehl-Neelsen stain<img src="/Users/michaelroth/AnkingImages/paste-25825638351115.jpg"><img src="/Users/michaelroth/AnkingImages/paste-24786256265570.jpg"><img src="/Users/michaelroth/AnkingImages/paste-23652384899428.jpg"></div></li></ul></li><li><div><b><u>Both</u> </b><i>Mycobacteria tuberculosis and leprae</i> stain <u>acid-fast</u> due to the <i>high concentration</i> of `{{c1::mycolic acids}}` in their <b>cell walls</b></div><ul><li><div><i><img src="/Users/michaelroth/AnkingImages/paste-24219320582507.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-71472550773094.jpg" /></i><i><br /></i><i>aka <font color="#fc5a8d">Ziehl-Neelsen</font> stain</i><i><br /></i><i>Isoniazid inhibits the formation of mycolic acid</i></div></li></ul></li><li><div><i>Mycobacteria tuberculosis</i> grows `{{c1::slow::fast or slow}}`, requiring `{{c1::2-6}}`<b> wks</b> to grow</div><ul><li></li></ul></li><li><div><i>Mycobacteria tuberculosis</i> grows on the `{{c1::L wenstein Jensen}}` agar</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-25378961752423.jpg" /></div></li></ul></li><li><div>What is the oxygen dependency of <i>Mycobacteria tuberculosis?</i><i><br /></i>`{{c1::Obligate aerobe}}`<i><br /></i></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-25524990640484.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-26383984099481.jpg" /></div></li></ul></li><li><div><i>M. tuberculosis</i> is transmitted via `{{c1::inhalation}}` of droplet nuclei (<b>airborne particles</b>)</div><ul><li><div>hence patients are placed in negative-pressure isolation rooms</div></li></ul></li><li><div><i>Mycobacteria tuberculosis</i> primarily resides and proliferates in `{{c1::macrophages::cell type}}`</div><ul><li><div>Cord factor stimulates TNF-a release which increase macrophage response. <br />Sulfatides inhibit phagolysosomal formation, resulting in necrosis of the proliferating macrophages and ultimately caseous necrosis development</div></li></ul></li><li><div><b>`{{c1::Cord factor}}`</b> allows for clumping of <i>Mycobacteria tuberculosis</i> in a <u>"`{{c2::serpentine}}`-like" formation</u></div><ul><li><div>present in <u>virulent strains only</u> - is a glycolipid on the bacterial cell wall<u><br /></u><u><img src="/Users/michaelroth/AnkingImages/paste-27565100106084.jpg" /></u></div></li></ul></li><li><div><b>Cord factor</b> of <i>Mycobacteria tuberculosis</i> stimulates <u>`{{c1::granuloma}}` formation</u> via induction of TNF-a </div><ul><li><div><i>TNF-a activates <u>macrophages</u> which form the granulomas</i></div></li></ul></li><li><div><b>`{{c3::Cord factor}}`</b> of <i>`{{c2::Mycobacteria tuberculosis}}`</i> activates <u>`{{c1::macrophages}}`</u> via induction of <u>`{{c1::TNF-a}}`,</u> which then form <b>granulomas</b>  </div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/Xnip2018-04-113_16-05-07.jpg" /></div></li></ul></li><li><div><b>Cord factor</b> of <i>Mycobacteria tuberculosis</i> is only present in `{{c1::virulent}}` strains of bacteria</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-30391188586645.jpg" /></div></li></ul></li><li><div><b>`{{c1::Sulfatides (surface glycolipids)}}`</b> of <i>Mycobacterium tuberculosis </i>inhibit <u>`{{c2::phagolysosome}}`</u> fusion</div><ul><li><div>allows TB to survive in cells like macrophagesmacrophages phagocytose TB, but cannot combine with lysosomes to degrade TB<img src="/Users/michaelroth/AnkingImages/paste-30893699760484.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-31026843746653.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-31310311588142.jpg" /></div></li></ul></li><li><div>Paths of Progression <i><u>after</u></i> <b>Primary <i>Mycobacteria tuberculosis</i></b> infection: healed `{{c1::latent}}` infection (<u>most common</u>)</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-31589484462438.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-32366873542954.jpg" /></div></li></ul></li><li><div>Paths of Progression <i><u>after</u></i> <b>Primary <i>Mycobacteria tuberculosis</i></b> infection: `{{c1::<u>disseminated/systemic</u>}}` infection aka `{{c2::<b>miliary</b>}}` tuberculosis</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-31589484462438.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-32152125178015.jpg" /></div></li></ul></li><li><div>Paths of Progression <i><u>after</u></i> <b>Primary <i>Mycobacteria tuberculosis</i></b> infection: `{{c1::<u>secondary</u>}}` infection, which occurs by <b>reactivated infection</b> due to `{{c2::immunosuppression}}` (<i>HIV, old age, cancer, etc</i>)</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-31589484462438.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-32366873542954.jpg" /></div></li></ul></li><li><div><b>`{{c2::Primary}}` infection</b> of <i>Mycobacterium tuberculosis </i>commonly affects the <u>`{{c1::middle}}`</u> and <u>`{{c1::lower}}` lobes</u> of the <b>lungs</b></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-35119947579981.jpg" /></div></li></ul></li><li><div><b>Primary</b> <i>`{{c2::Mycobacteria tuberculosis}}` </i>infection is diagnosed via presence of the <u>`{{c1::Ghon}}` complex</u></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-34080565494111.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-35119947579981.jpg" /></div></li></ul></li><li><div>The <u>Ghon complex</u> of <i>Primary tuberculosis</i> includes <b>`{{c1::hilar}}` lymphadenopathy</b> with <b>`{{c1::Ghon}}` foci</b> in the middle and lower lobes of the lungs</div><ul><li><div><img src="/Users/michaelroth/AnkingImages/paste-34076270526815.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-35119947579981.jpg" />Ghon foci are caseating (necrotic) granulomas near the pleura of the middle and lower lobes</div></li></ul></li><li><div>A(n)&nbsp;<u>`{{c2::Ghon focus}}`</u> is a(n) `{{c1::<b>caseating</b> <b>granuloma::specific</b>}}` located <i>near the pleura</i> in the middle or lower lobes of the lung (<b>tuberculosis</b> infection)</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-34076270526815.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-35124242547277.jpg" /></div></li></ul></li><li><div>The granulomas of a <b>Ghon focus</b> are <b>`{{c1::caseating}}` granulomas</b>, meaning they have a <u>central area of `{{c2::necrotic macrophages::specific cell}}`</u></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-35119947579981.jpg"><img src="/Users/michaelroth/AnkingImages/paste-36730560315749.jpg"></div></li></ul></li><li><div><b>Caseating granulomas</b> with a <u>central necrosis</u> and <u>`{{c1::Langhans giant::specific}}` cells</u> are characteristic of <b>secondary tuberculosis</b></div><ul><li><div><img src="/Users/michaelroth/AnkingImages/paste-38611755991284.jpg" />Langhans giant cells denoted by the <b><u>arrow</u></b>, caseating granuloma with central necrosis in upper left</div></li></ul></li><li><div>Most cases of <b>primary tuberculosis</b> occur in `{{c1::children::demographic}}` and the immunocompromised&nbsp;</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-39505109188951.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-39517994090850.jpg" /></div></li></ul></li><li><div>Most cases of <b>primary tuberculosis </b>resolve, healing via `{{c1::<b>fibrosis</b>}}` and `{{c2::<b>calcification</b>}}`, becoming <u>`{{c3::latent}}`</u></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-39505109188951.jpg" draggable="false"><img src="/Users/michaelroth/AnkingImages/paste-39517994090850.jpg" draggable="false"></div></li></ul></li><li><div><i>Latent</i> <u>tuberculosis</u> infections result in a <b><u>positive</u> `{{c1::purified protein derivative (PPD+)}}` skin test</b></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-40643275522143.jpg"><br><img src="/Users/michaelroth/AnkingImages/paste-40617505718627.jpg"></div></li></ul></li><li><div>Exposure to <i>`{{c1::Mycobacterium tuberculosis::bug name}}`</i> will always* result in a <u>positive PPD test</u></div><ul><li><div>*unless the patient is immunosuppressed (e.g. AIDS)</div></li></ul></li><li><div>The `{{c1::BCG}}` vaccine can result in a <u>false positive</u> <b>PPD test</b></div><ul><li><div>Extra <br><br><img src="/Users/michaelroth/AnkingImages/paste-41661182771291.jpg" draggable="false"><img src="/Users/michaelroth/AnkingImages/paste-41639707935075.jpg" draggable="false"></div></li></ul></li><li><div>What is the prognosis for <u>miliary tuberculosis</u>?<br />`{{c1::Poor (100% fatality if not treated)}}`</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-42039139893819.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-42567420871011.jpg" /></div></li></ul></li><li><div><u>Miliary tuberculosis</u> develops when the infection is <b>disseminated into the `{{c1::blood (bacteremia)}}`</b></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-42039139893819.jpg" /></div></li></ul></li><li><div><u>`{{c1::Miliary}}` tuberculosis</u> can result in <b>granuloma formation</b> in the <u>spleen</u>, <u>liver</u>, <u>adrenal gland</u> and <u>meninges</u> (causing meningitis)</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-42039139893819.jpg" /></div></li></ul></li><li><div>Inhibition of `{{c1::TNF-a}}` (e.g. immunosuppression, drugs) results in lack of granuloma formation and resultant <b>reactivation of tuberculosis</b></div><ul><li><div>***individuals who are to be started on a TNF-a inhibitor<br> (e.g.&nbsp;<b>infliximab</b>) should receive a PPD test<br>lack of TNF-a = lack of granuloma = lack of containment of tuberculosis<img src="/Users/michaelroth/AnkingImages/paste-45659797324130.jpg"></div></li></ul></li><li><div><u>Reactivated tuberculosis</u> affects the `{{c1::upper}}` lobes of the lung</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-46544560587300.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-46780783788380.jpg" /></div></li></ul></li><li><div><b>Cough</b>, <b>night `{{c2::sweats}}`</b>, and `{{c2::<b>hemoptysis</b>}}` are symptoms of <u>`{{c1::reactivated}}`</u> <i>Mycobacterium tuberculosis</i> infection</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-47364899340639.jpg"><img src="/Users/michaelroth/AnkingImages/paste-46544560587300.jpg"></div></li></ul></li><li><div><b>CNS involvement</b> of disseminated <i>Mycobacteria tuberculosis</i> can result in `{{c1::<b>meningitis</b>}}` as well as <b><u>cavitary</u></b> lesions known as <u>`{{c2::tuberculomas}}`</u></div><ul><li><div>occur in the <u>base</u> of the brain<br /><img src="/Users/michaelroth/AnkingImages/paste-48752173777255.jpg" /></div></li></ul></li><li><div><u>`{{c1::Active}}`</u> <i>Mycobacterium tuberculosis </i>infection is treated with <b>RIPE</b> therapy</div><ul><li><div><i>Rifampin, Isoniazid, Pyrazinamide, Ethambutol (or streptomycin)</i><img src="/Users/michaelroth/AnkingImages/ripe.png"></div></li></ul></li><li><div><u>Active</u> <i>Mycobacterium tuberculosis </i>infection is treated with <b>RIPE</b> therapy:<br>-&nbsp;<span style="color: rgb(252, 2, 128);">R</span>`{{c1::ifampin}}`-&nbsp;<span style="color: rgb(252, 2, 128);">I</span>`{{c2::soniazid}}`-&nbsp;<span style="color: rgb(252, 2, 128);">P</span>`{{c3::yrazinamide}}`- <span style="color: rgb(252, 2, 128);">E</span>`{{c4::thambutol (or streptomycin)}}`</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/ripe.png" /></div></li></ul></li><li><div><b>Isoniazid</b> is administered with `{{c1::pyridoxine (Vitamin B<sub>6</sub>)}}` in patients at risk for <u>peripheral neuropathy</u> as well as those who are pregnant, breastfeeding or have epilepsy</div><ul><li><div><i>recall that Isoniazid can result in B<sub>6</sub> deficiency and ultimately B<sub>3</sub> deficiency (need B<sub>6</sub> and B<sub>2</sub> for B<sub>3</sub>)</i><i><br /></i><i><img src="/Users/michaelroth/AnkingImages/paste-60653528154573.jpg" /></i></div></li></ul></li><li><div>A(n)&nbsp;<u>`{{c2::Ranke}}` complex</u> is a Ghon complex that has undergone progressive fibrosis and subsequent <b>`{{c1::calcification}}`</b></div><ul><li><div><i>are now radiologically detectable***</i><i><img src="/Users/michaelroth/AnkingImages/paste-52613349376541.jpg"></i></div></li></ul></li><li><div>Diagnosis of <b>active primary tuberculosis</b> is made by chest x-ray (CXR) demonstrating a(n)&nbsp;<u>`{{c1::Ghon}}` complex</u> and <u>`{{c1::pleural}}` effusion</u></div><ul><li><div><i>when a Ghon complex heals and calcifies further, it is to as a <b>Ranke</b> <b>complex - </b>calcifications allows it to be identified radiologically</i><i><br></i>The Ghon complex precedes the development of a Ranke complex, in that a Ghon complex is seen in untreated primary pulmonary tuberculosis infection with Ghon lesion fibrosis while the Ranke complex is a result of the healing of a primary tuberculosis Ghon complex characterized by a calcified Ghon lesion and calcified mediastinal lymph nodes<i><br></i></div></li></ul></li><li><div>What test for tuberculosis does not cross-react with BCG vaccine?<br />`{{c1::Quantiferon Gold assay}}`</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-53721450938493.jpg" /></div></li></ul></li><li><div>The <b>Quantiferon Gold assay</b> measures <u>`{{c1::IFN-gamma}}` levels</u> <b>released from `{{c1::Th1-cells}}`</b> exposed to <i>Mycobacterium tuberculosis</i></div><ul><li></li></ul></li><li><div>Kidney infection of <i>Mycobacterium tuberculosis </i>results in <u>RBCs and WBCs in urine</u> <i>WITHOUT</i> <b>bacteria</b>, known as `{{c1::sterile pyuria}}`</div><ul><li><div><i>WBC casts will be present in urine</i></div></li></ul></li><li><div><i>Mycobacterium `{{c2::leprae}}`</i> thrives in <u>`{{c1::cool}}` temperatures</u>, explaining its predilection for `{{c1::extremities}}` of the body</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-70703751627111.jpg" /></div></li></ul></li><li><div><i>Mycobacteria leprae</i> grows extensively in `{{c1::armadillos::animal}}`, which have a cooler core body temperature</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-72468983185763.jpg" /></div></li></ul></li><li><div><b>Leprosy</b> is caused by <i>`{{c1::Mycobacteria leprae}}`</i> and is also known as <b>`{{c2::Hansen's}}` disease</b></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-72468983185763.jpg" /></div></li></ul></li><li><div><i>Mycobacteria leprae</i> can cause `{{c1::<b>tuberculoid</b>}}` and `{{c2::<b>lepromatous</b>}}` leprosy</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-73804718014606.jpg"><br></div></li></ul></li><li><div><b>`{{c1::Tuberculoid}}` leprosy</b> is associated with a strong <b>`{{c2::Th<sub>1</sub>}}`-cell</b> response, allowing for <u>`{{c2::cell-mediated}}` immunity</u></div><ul><li><div><i>Mediates granuloma formation</i><i><br /></i><i>recall that Th<sub>1</sub> cells are responsible for cell-mediated immunity</i><i><img src="/Users/michaelroth/AnkingImages/paste-74071005987173.jpg" /></i></div></li></ul></li><li><div><u>`{{c2::Tuberculoid}}` leprosy</u> is <b>able</b> to be contained within `{{c1::<b>macrophages</b>}}`</div><ul><li><div><i>Th<sub>1</sub> cells show a strong response, allowing for cell-mediated immunity</i><i><img src="/Users/michaelroth/AnkingImages/paste-74706661146983.jpg" /></i></div></li></ul></li><li><div><i>Well-demarcated</i>, hairless, <b>hypoesthetic</b>, <b>hypopigmented</b> <u>skin plaques</u> are common in <b>`{{c1::Tuberculoid}}` leprosy</b></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-76257144340858.jpg"><img src="/Users/michaelroth/AnkingImages/paste-75909251989861.jpg"><img src="/Users/michaelroth/AnkingImages/paste-36485747179640.jpg"></div></li></ul></li><li><div>A <b>positive</b> <u>`{{c1::Lepromin}}` skin test</u> demonstrates a good <u>cell-mediated response</u> in `{{c2::<b>Tuberculoid leprosy</b>}}`</div><ul><li><div>recall cell-mediated response is Th1 mediated<img src="/Users/michaelroth/AnkingImages/paste-77360950935909.jpg" /></div></li></ul></li><li><div><b>`{{c1::Lepromatous}}` leprosy</b> is associated with a strong <b>`{{c2::Th<sub>2</sub>}}`-cell</b> response, allowing for <u>`{{c2::humoral}}` immunity</u></div><ul><li><div> <i>Lack of Th<sub>1</sub></i>  response results in lack of cell-mediated immunity and therefore lack of containment of the infection<br><i><img src="/Users/michaelroth/AnkingImages/paste-77962246357346.jpg" draggable="false" class="resizer"></i> <i><img src="/Users/michaelroth/AnkingImages/paste-36481452212344.jpg" draggable="false" class="resizer"></i> </div></li></ul></li><li><div><u>`{{c1::Lepromatous}}` leprosy</u> is <b>unable</b> to be contained within <b>macrophages</b>, allowing for <u>diffuse inflammatory damage</u></div><ul><li><div><i>Lack of Th<sub>1</sub></i> response results in lack of cell-mediated immunity and therefore lack of containment of the infection<i><img src="/Users/michaelroth/AnkingImages/paste-78576426680678.jpg"></i><i><img src="/Users/michaelroth/AnkingImages/paste-36481452212344.jpg"></i></div></li></ul></li><li><div>Which form of <b>Leprosy</b> (<i>Mycobacteria leprae</i>) is <u>communicable</u> (human to human)?<br />`{{c1::Lepromatous leprosy}}`</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-79864916869478.jpg" /></div></li></ul></li><li><div><u>`{{c2::Lepromatous}}` leprosy</u> presents with a <i>symmetrical</i> `{{c1::<b>glove</b>}}` and `{{c1::<b>stocking</b>}}` <b>neuropathy</b></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-80333068304738.jpg" /></div></li></ul></li><li><div><i>Poorly-demarcated</i> raised lesions on <u>extensor surfaces</u> of the extremities is characteristic of <b>`{{c1::Lepromatous}}` leprosy</b></div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-80796924772706.jpg" /><img src="/Users/michaelroth/AnkingImages/paste-1391569404025.jpg" /></div></li></ul></li><li><div>"<b>Leonine facies</b>" are characteristic of `{{c1::<u>Lepromatous</u> leprosy (<i>Mycobacteria leprae</i>)}}`</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-81780472283495.jpg" /></div></li></ul></li><li><div>Loss of eyebrows is characteristic of `{{c1::Lepromatous}}` <b>leprosy</b></div><ul><li><div><font color="#fc0280">L</font>eonine facies of <font color="#fc0280">L</font>epromatous <font color="#fc0280">L</font>eprosy<img src="/Users/michaelroth/AnkingImages/paste-81780472283495.jpg"><img src="/Users/michaelroth/AnkingImages/paste-1387274436729.jpg"></div></li></ul></li><li><div>A <u>saddle-nose (thick)</u> with <b>thick cheeks</b> is characteristic of `{{c1::Lepromatous}}` <b>leprosy</b></div><ul><li><div><font color="#fc0280">L</font>eonine facies of <font color="#fc0280">L</font>epromatous <font color="#fc0280">L</font>eprosy<img src="/Users/michaelroth/AnkingImages/paste-81780472283495.jpg"></div></li></ul></li><li><div><b>Infertility</b> due to <u>testicular involvement</u> is characteristic of `{{c1::Lepromatous}}` <b>leprosy</b></div><ul><li><div>infection spreads due to lack of Th<sub>1</sub> (cell-mediated) response and containment</div></li></ul></li><li><div>Treatment of the <u>`{{c2::Tuberculoid}}` form</u> of <b>Leprosy</b> includes `{{c1::<b>Rifampin</b>}}` and `{{c1::<b>Dapsone</b>}}` for `{{c3::6 months::time}}`&nbsp;</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-83240761164132.jpg" /></div></li></ul></li><li><div>Treatment of the <u>`{{c1::Lepromatous}}` form</u> of <b>Leprosy</b> includes <b>Rifampin</b>, <b>Dapsone </b>and `{{c2::<b>Clofazimine</b>}}` for `{{c2::24 months to 5 years::time}}`&nbsp;</div><ul><li><div>Extra <br><img src="/Users/michaelroth/AnkingImages/paste-90679644520817.jpg" /></div></li></ul></li><li><div><i>Mycobacterium leprae</i> is an obligate `{{c1::intracellular}}` bacteria</div><ul><li></li></ul></li></ul>